All prices include GST and are in NZ dollars

  • MAVIRET Quality Use of Medicines - On Demand

    Infections On Demand

    • $0.00 incl. GST for PSNZ members
    • $0.00 incl. GST for non-members

    MAVIRET® is a fully funded hepatitis C prescription medicine on the Pharmaceutical Schedule since February 2019.

    If you wish to dispense MAVIRET®, pharmacists are required to complete the College MAVIRET® Quality Use of Medicines training course and your pharmacy needs to be enrolled in the AbbVie Care Pharmacy Programme.

    read more ≻

  • Medicines Therapy Assessment (MTA) Portfolio

    Accreditation Course On Demand

    • $360.00 incl. GST for PSNZ members
    • $1,080.00 incl. GST for non-members

    The Medicines Therapy Assessment (MTA) is a systematic, patient-centred clinical assessment of all medicines currently taken by a patient, identifying, resolving and preventing medication-related problems as well as optimising the effectiveness of medication treatment.

    read more ≻

  • Medicines Use Review Accreditation Training Programme

    On Demand Pharmacy Services

    • $360.00 incl. GST for PSNZ members
    • $1,080.00 incl. GST for non-members

    The accreditation training programme needed to become accredited to undertake Medicines Use Reviews.

    read more ≻

  • Molnupiravir (Lagevrio) - what a pharmacist needs to know

    Infections On Demand

    • $0.00 incl. GST for PSNZ members
    • $180.00 incl. GST for non-members

    This course provides information about Molnupiravir (Lagevrio®) the evidence, mechanism of action, a discussion of safety concerns and the management of interactions and use in different populations. The supply and patient eligibility criteria are also discussed.

    read more ≻

  • Nirmatrelvir/Ritonavir (PaxlovidTM) – what a pharmacist needs to know

    Infections On Demand

    • $0.00 incl. GST for PSNZ members
    • $180.00 incl. GST for non-members

    This course provides information about Nirmatrelvir/Ritonavir (PaxlovidTM), the evidence, mechanism of action and interaction management. The supply and patient eligibility criteria are also discussed.

    read more ≻